Group One Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Group One Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,300	Closed	-$208K	–	9147
2021 Q3	$208K	Buy	10,300 +7,700	+296%	+$213K	﹤0.01%	5135
2021 Q2	$97K	Buy	2,600 +500	+24%	+$15.3K	﹤0.01%	5998
2021 Q1	$54K	Sell	2,100 -9,700	-82%	-$248K	﹤0.01%	6172
2020 Q4	$260K	Buy	+11,800	New	+$260K	﹤0.01%	3864
2020 Q3	–	Sell	-35,600	Closed	-$904K	–	6748
2020 Q2	$904K	Buy	+35,600	New	+$767K	﹤0.01%	2120
2018 Q4	–	Sell	-300	Closed	-$5K	–	5645
2018 Q3	$5K	Hold	300	–	–	﹤0.01%	4869
2018 Q2	$4K	Sell	300 -1,600	-84%	-$20.1K	﹤0.01%	4869
2018 Q1	$18K	Sell	1,900 -24,100	-93%	-$260K	﹤0.01%	4132
2017 Q4	$235K	Buy	26,000 +20,600	+381%	+$152K	﹤0.01%	2823
2017 Q3	$31K	Buy	+5,400	New	+$19.6K	﹤0.01%	3869

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Group One Trading's DRNA Position: Q2 2021 in Review

Group One Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 2,385 shares — an estimated $73.1K sold.

Group One Trading first reported a position in DRNA in Q3 2017 and held it in 3 quarters. The position peaked at $1.11M in Q3 2020. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

Group One Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Group One Trading sold 2,385 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $73.1K.
Group One Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
Group One Trading's Dicerna Pharmaceuticals, Inc. position peaked at $1.11M in Q3 2020.
203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.